SENSEX 77414.92 ▼ (0.25%)
BSE BANKEX 59542.38 ▲ (0.36%)

Fredun Pharmaceuticals

BSE: 539730 09 Sep 2025
Healthcare
₹ 1270
Fredun Pharmaceuticals Limited specializes in Pharmaceuticals within the Healthcare sector.

Fredun Pharmaceuticals - Share Price & Details

Market Cap
₹626.0
High /Low
1,340 / 635.0
Stock P/E
26.7
Book Value
₹299.0
Dividend Yield
0.05
ROCE
18.9
ROE
₹15.8
Face Value
10.0
PEG Ratio
0.55
EVEBITDA
₹12.8
Debt
166
CMP / FCF
-28.0
Debt to equity
₹1.18
NP Ann
20.8
High price all time
1,428
Piotroski score
₹4.0
Graham Number
578.0
No. Eq. Shares
0.47
Net CF
₹3.47
Net profit
23.4
Price to book value
4.43
Interest Coverage
₹2.27
Low price all time
12.5
Industry PE
33.4
Reserves
₹137
Free Cash Flow
₹-34.9

Price Chart


Volume Chart


Peer Comparison

Stock Total Income Net Profit Net Sales EPS Market Cap (in Cr) P/E
FABINO ENTERPRISES LIMITEDNANANANA5.4691.0
Triochem Products Ltd.,NANANANA0
Fredun Pharmaceuticals LimitedNANANANA626.026.7
VENUS REMEDIES LTD.1398.5116.91318.58.7561113.1
KERALA AYURVEDA LTD.NANANANA582

Peer Comparison Chart


About Fredun Pharmaceuticals

Fredun Pharmaceuticals Limited, with Security Code 539730, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.


Latest News

Fredun Pharmaceuticals Achieves 52-Week High Amid Strong Market Confidence and Growth Metrics

(25 Aug 2025)
Fredun Pharmaceuticals has achieved a new 52-week high stock price of Rs. 1285, reflecting strong market confidence and impressive performance.
Read more →

Fredun Pharmaceuticals Achieves 52-Week High Amid Strong Financial Growth and Market Outperformance

(22 Aug 2025)
Fredun Pharmaceuticals has achieved a new 52-week high in stock price, reflecting strong performance in the Pharmaceuticals & Biotechnology sector.
Read more →

Fredun Pharmaceuticals soars 62% following InvestingPro’s February Fair Value alert By Investing.com

(08 Aug 2025)
When InvestingPro's Fair Value models identified Fredun Pharmaceuticals Limited (BO:FRED) as significantly undervalued in February 2025,...
Read more →

Fredun Pharmaceuticals Achieves 52-Week High Amidst Market Challenges and Strong Growth Metrics

(06 Aug 2025)
Fredun Pharmaceuticals has achieved a new 52-week high stock price of Rs. 1030, reflecting strong performance in the Pharmaceuticals...
Read more →

Fredun Pharmaceuticals standalone net profit rises 63.92% in the June 2025 quarter

(04 Aug 2025)
Net profit of Fredun Pharmaceuticals rose 63.92% to Rs 6.77 crore in the quarter ended June 2025 as against Rs 4.13 crore during the...
Read more →

Fredun Pharmaceuticals Achieves 52-Week High Amid Strong Financial Growth and Market Performance

(31 Jul 2025)
Fredun Pharmaceuticals has achieved a new 52-week high in stock price, reflecting strong performance in the Pharmaceuticals & Biotechnology sector.
Read more →

Company Updates